Amgen (AMGN) Successfully Completes Acquisition Of Five Prime Therapeutics (FPRX)
Tweet Send to a Friend
Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE